Odonate Therapeutics Inc. (NASDAQ:ODT) went up by 14.68% from its latest closing price compared to the recent 1-year high of $28.41. The company’s stock price has collected -14.38% of loss in the last five trading sessions. Press Release reported on 01/07/22 that Odonate Announces Expected Delisting of Its Stock
Is It Worth Investing in Odonate Therapeutics Inc. (NASDAQ :ODT) Right Now?
Plus, the 36-month beta value for ODT is at 0.45.
ODT currently public float of 37.79M and currently shorts hold a 1.57% ratio of that float. Today, the average trading volume of ODT was 821.14K shares.
ODT’s Market Performance
ODT stocks went down by -14.38% for the week, with a monthly drop of -28.57% and a quarterly performance of -57.04%, while its annual performance rate touched -93.87%. The volatility ratio for the week stands at 18.32% while the volatility levels for the past 30 days are set at 11.31% for Odonate Therapeutics Inc.. The simple moving average for the period of the last 20 days is -12.68% for ODT stocks with a simple moving average of -58.33% for the last 200 days.
Analysts’ Opinion of ODT
Many brokerage firms have already submitted their reports for ODT stocks, with Jefferies repeating the rating for ODT by listing it as a “Hold.” The predicted price for ODT in the upcoming period, according to Jefferies is $4 based on the research report published on March 22nd of the previous year 2021.
ODT Trading at -38.08% from the 50-Day Moving Average
After a stumble in the market that brought ODT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -95.60% of loss for the given period.
Volatility was left at 11.31%, however, over the last 30 days, the volatility rate increased by 18.32%, as shares sank -17.76% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -59.94% lower at present.
During the last 5 trading sessions, ODT fell by -14.38%, which changed the moving average for the period of 200-days by -59.55% in comparison to the 20-day moving average, which settled at $1.4180. In addition, Odonate Therapeutics Inc. saw -7.41% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at ODT starting from EcoR1 Capital, LLC, who sale 5,545,000 shares at the price of $1.65 back on Dec 10. After this action, EcoR1 Capital, LLC now owns 0 shares of Odonate Therapeutics Inc., valued at $9,147,420 using the latest closing price.
EcoR1 Capital, LLC, the 10% Owner of Odonate Therapeutics Inc., sale 156,669 shares at $1.82 during a trade that took place back on Dec 09, which means that EcoR1 Capital, LLC is holding 5,545,000 shares at $284,981 based on the most recent closing price.
Stock Fundamentals for ODT
The total capital return value is set at -83.33, while invested capital returns managed to touch -82.89. Equity return is now at value -102.70, with -76.30 for asset returns.
Based on Odonate Therapeutics Inc. (ODT), the company’s capital structure generated 3.91 points at debt to equity in total, while total debt to capital is 3.76. Total debt to assets is 3.17, with long-term debt to equity ratio resting at 3.43. Finally, the long-term debt to capital ratio is 3.30.
The liquidity ratio also appears to be rather interesting for investors as it stands at 5.91.